This joint white paper recommends the implementation of well-designed NFC systems coupled with legislative liability protections for pandemic vaccines to ensure both equitable compensation and adequate vaccine coverage in a future pandemic.
Read moreDiscover how the innovative pharmaceutical industry works with partners to advance the SDGs
Read moreAhead of the Global Fund Seventh Replenishment for 2024-2026, the innovative biopharmaceutical industry reaffirms its longstanding commitment to support the Global Fund mission to defeat HIV, TB, and malaria, and ensure a healthier, safer, more equitable future for all.
Read more